Title : The safety, tolerability, and efficacy of once-daily memantine (28 mg): a multinational, randomized, double-blind, placebo-controlled trial in patients with moderate-to-severe Alzheimer's disease taking cholinesterase inhibitors - Grossberg_2013_CNS.Drugs_27_469 |
Author(s) :
Grossberg GT , Manes F , Allegri RF , Gutierrez-Robledo LM , Gloger S , Xie L , Jia XD , Pejovic V , Miller ML , Perhach JL , Graham SM |
Ref :
CNS Drugs , 27 :469 , 2013 |
Abstract : Grossberg_2013_CNS.Drugs_27_469 |
ESTHER : Grossberg_2013_CNS.Drugs_27_469 |
PubMedSearch : Grossberg_2013_CNS.Drugs_27_469 |
PubMedID: 23733403 |